ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,210 | +3.5% | 12,553 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $248,435 | +20.1% | 12,503 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $206,793 | -19.8% | 12,072 | -8.4% | 0.00% | 0.0% |
| Q4 2022 | $257,815 | +54.4% | 13,174 | +26.9% | 0.00% | 0.0% |
| Q3 2022 | $167,000 | +20.1% | 10,381 | +3.4% | 0.00% | – |
| Q2 2022 | $139,000 | -39.3% | 10,043 | -30.3% | 0.00% | – |
| Q1 2022 | $229,000 | -41.9% | 14,408 | -20.3% | 0.00% | -100.0% |
| Q4 2021 | $394,000 | -29.9% | 18,083 | -3.8% | 0.00% | -50.0% |
| Q3 2021 | $562,000 | -41.5% | 18,804 | -13.3% | 0.00% | -33.3% |
| Q2 2021 | $961,000 | +18.1% | 21,696 | +18.3% | 0.00% | 0.0% |
| Q1 2021 | $814,000 | -7.6% | 18,343 | +14.2% | 0.00% | 0.0% |
| Q4 2020 | $881,000 | +194.6% | 16,068 | +22.9% | 0.00% | +200.0% |
| Q3 2020 | $299,000 | +6.4% | 13,070 | -2.8% | 0.00% | -50.0% |
| Q2 2020 | $281,000 | -17.4% | 13,443 | -9.9% | 0.00% | 0.0% |
| Q4 2019 | $340,000 | +70.9% | 14,924 | -12.6% | 0.00% | +100.0% |
| Q3 2019 | $199,000 | -22.9% | 17,070 | -0.7% | 0.00% | -50.0% |
| Q2 2019 | $258,000 | -15.1% | 17,185 | -0.8% | 0.00% | 0.0% |
| Q1 2019 | $304,000 | +30.5% | 17,318 | +10.3% | 0.00% | 0.0% |
| Q4 2018 | $233,000 | – | 15,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |